Association between percutaneous coronary intervention and long-term C-reactive protein levels in patients with acute coronary syndromes View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2010-07

AUTHORS

Kausik K. Ray, Babak Nazer, Richard Cairns, C. Michael Gibson, Christopher P. Cannon

ABSTRACT

C-reactive protein (CRP) is an independent predictor of risk in ACS patients, and it has been previously shown that percutaneous coronary intervention (PCI) is associated with an early rise in CRP. To assess the long-term relationship between PCI and CRP, we compared CRP levels at baseline, 30 days, 4 months and 24 months among patients in the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trial who were treated with PCI and those who did not receive PCI. At study entry, CRP was significantly higher among patients who had undergone PCI (13.2 vs. 9.5 mg/l, P < 0.001). However, by day 30 CRP was significantly lower among patients who had undergone PCI for management of the index event (1.5 vs. 2.1 mg/l, P < 0.001) and remained lower at 4 months and by end of study (average 2 years after ACS). Using a multivariable model, we observed that PCI was associated with 8.6% lower CRP level at month 4 (P = 0.05) and 14.2% at approximately 2 years (P = 0.0028). These analyses suggest that although PCI may acutely increase inflammation, it may also serve a role in decreasing inflammation associated with atherosclerotic plaques via long-term mechanical stabilization. More... »

PAGES

10-13

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11239-010-0463-7

DOI

http://dx.doi.org/10.1007/s11239-010-0463-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1023994433

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20354760


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acute Coronary Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angioplasty, Balloon, Coronary", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Atherosclerosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Atorvastatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "C-Reactive Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heptanoic Acids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hydroxymethylglutaryl-CoA Reductase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Inflammation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Observation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pravastatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrroles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Cambridge", 
          "id": "https://www.grid.ac/institutes/grid.5335.0", 
          "name": [
            "Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ray", 
        "givenName": "Kausik K.", 
        "id": "sg:person.0651160077.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651160077.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Brigham and Women's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.62560.37", 
          "name": [
            "Department of Internal Medicine, Brigham and Women\u2019s Hospital, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nazer", 
        "givenName": "Babak", 
        "id": "sg:person.01235024064.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235024064.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Worldwide Clinical Trials, Nottingham, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cairns", 
        "givenName": "Richard", 
        "id": "sg:person.01370013504.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370013504.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Cardiovascular Division, Beth Israel/Deaconess Hospital, Harvard Medical School, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Michael Gibson", 
        "givenName": "C.", 
        "id": "sg:person.0750215673.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750215673.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Thrombolysis in Myocardial Infarction Study Group", 
          "id": "https://www.grid.ac/institutes/grid.492942.0", 
          "name": [
            "Thrombolysis in Myocardial Infarction (TIMI) Study Group, Cardiovascular Division, Brigham and Women\u2019s Hospital and Harvard Medical School, 75 Francis St, 02115, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cannon", 
        "givenName": "Christopher P.", 
        "id": "sg:person.01172544713.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172544713.06"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1161/circulationaha.105.586347", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000843350"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.104.2.163", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002436923"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa040583", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024700175"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm200106213442501", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025910550"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjcard.2003.09.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026083053"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.0000060541.18923.e9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028923218"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9149(02)02615-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029868075"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2005.03.077", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030759611"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.106.628909", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033284354"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(05)67222-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036049136"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1067/mhj.2003.16", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037102433"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa042378", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040605046"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1067/mhj.2003.65", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044385512"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1067/mhj.2003.65", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044385512"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0008-6363(99)00175-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054580480"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-07", 
    "datePublishedReg": "2010-07-01", 
    "description": "C-reactive protein (CRP) is an independent predictor of risk in ACS patients, and it has been previously shown that percutaneous coronary intervention (PCI) is associated with an early rise in CRP. To assess the long-term relationship between PCI and CRP, we compared CRP levels at baseline, 30 days, 4 months and 24 months among patients in the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trial who were treated with PCI and those who did not receive PCI. At study entry, CRP was significantly higher among patients who had undergone PCI (13.2 vs. 9.5 mg/l, P < 0.001). However, by day 30 CRP was significantly lower among patients who had undergone PCI for management of the index event (1.5 vs. 2.1 mg/l, P < 0.001) and remained lower at 4 months and by end of study (average 2 years after ACS). Using a multivariable model, we observed that PCI was associated with 8.6% lower CRP level at month 4 (P = 0.05) and 14.2% at approximately 2 years (P = 0.0028). These analyses suggest that although PCI may acutely increase inflammation, it may also serve a role in decreasing inflammation associated with atherosclerotic plaques via long-term mechanical stabilization.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11239-010-0463-7", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1113719", 
        "issn": [
          "0929-5305", 
          "1573-742X"
        ], 
        "name": "Journal of Thrombosis and Thrombolysis", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "30"
      }
    ], 
    "name": "Association between percutaneous coronary intervention and long-term C-reactive protein levels in patients with acute coronary syndromes", 
    "pagination": "10-13", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "725003c384b0b39b8fde8a8e7c74992db0a04563afa2257dc46c92519374efd9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20354760"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9502018"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11239-010-0463-7"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1023994433"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11239-010-0463-7", 
      "https://app.dimensions.ai/details/publication/pub.1023994433"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T10:15", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000348_0000000348/records_54297_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11239-010-0463-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11239-010-0463-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11239-010-0463-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11239-010-0463-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11239-010-0463-7'


 

This table displays all metadata directly associated to this object as RDF triples.

213 TRIPLES      21 PREDICATES      59 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11239-010-0463-7 schema:about N1225dbda177d44dd9625d98cb8a94ac4
2 N4dc318b247dd4953adf15e1780614264
3 N53b28a6119bd4b40a0ac8c0d4fdea666
4 N71b5a606f828479c819b7056a95a7c53
5 N900eadc0a940476fb162bed93491db25
6 N9a1309a29d6f48eda0748ef4b5e46951
7 Nb1841e70596345d2b0860447cfb0382a
8 Nb7fb28278b5948959a50545a615c8970
9 Nca26a2177bf64f2db8235c91d4378f1a
10 Nd675d8b0c1c04dd9bbe1e8b5b7acc4f9
11 Nde12b014ac2a464ab20a4f36619b3b95
12 Ne308b96c44344d008ba11ad8b857d0b2
13 Ne3cd39706e5d4e06be1c43f6dbd55839
14 Nee67c799ac4c44d3a033b7a4618b74c6
15 Nf8c7a6a9bfba4567a61dd8dc9d55af7d
16 Nfe53f92e89e143f28bd436ee622f72a3
17 anzsrc-for:11
18 anzsrc-for:1103
19 schema:author N5598264e33704ae381e44be23b0c0fc3
20 schema:citation https://doi.org/10.1016/j.amjcard.2003.09.006
21 https://doi.org/10.1016/j.jacc.2005.03.077
22 https://doi.org/10.1016/s0002-9149(02)02615-2
23 https://doi.org/10.1016/s0008-6363(99)00175-3
24 https://doi.org/10.1016/s0140-6736(05)67222-4
25 https://doi.org/10.1056/nejm200106213442501
26 https://doi.org/10.1056/nejmoa040583
27 https://doi.org/10.1056/nejmoa042378
28 https://doi.org/10.1067/mhj.2003.16
29 https://doi.org/10.1067/mhj.2003.65
30 https://doi.org/10.1161/01.cir.0000060541.18923.e9
31 https://doi.org/10.1161/01.cir.104.2.163
32 https://doi.org/10.1161/circulationaha.105.586347
33 https://doi.org/10.1161/circulationaha.106.628909
34 schema:datePublished 2010-07
35 schema:datePublishedReg 2010-07-01
36 schema:description C-reactive protein (CRP) is an independent predictor of risk in ACS patients, and it has been previously shown that percutaneous coronary intervention (PCI) is associated with an early rise in CRP. To assess the long-term relationship between PCI and CRP, we compared CRP levels at baseline, 30 days, 4 months and 24 months among patients in the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trial who were treated with PCI and those who did not receive PCI. At study entry, CRP was significantly higher among patients who had undergone PCI (13.2 vs. 9.5 mg/l, P < 0.001). However, by day 30 CRP was significantly lower among patients who had undergone PCI for management of the index event (1.5 vs. 2.1 mg/l, P < 0.001) and remained lower at 4 months and by end of study (average 2 years after ACS). Using a multivariable model, we observed that PCI was associated with 8.6% lower CRP level at month 4 (P = 0.05) and 14.2% at approximately 2 years (P = 0.0028). These analyses suggest that although PCI may acutely increase inflammation, it may also serve a role in decreasing inflammation associated with atherosclerotic plaques via long-term mechanical stabilization.
37 schema:genre research_article
38 schema:inLanguage en
39 schema:isAccessibleForFree false
40 schema:isPartOf N02b2fedd64de41e88a7f711868a75c08
41 N920adf81cf0549cbaf0b3a87e6f7565e
42 sg:journal.1113719
43 schema:name Association between percutaneous coronary intervention and long-term C-reactive protein levels in patients with acute coronary syndromes
44 schema:pagination 10-13
45 schema:productId N36e197056fdc4001b8c7d3aae79cad90
46 N5b9ee280c5ca4a28aedd028161b5d05c
47 N83f628dd53394e1eb4f246319d8960a4
48 N8aabf787ad294931bccbb3a5946a7ca7
49 Nb02921f9121647d19e925076faa37bb7
50 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023994433
51 https://doi.org/10.1007/s11239-010-0463-7
52 schema:sdDatePublished 2019-04-11T10:15
53 schema:sdLicense https://scigraph.springernature.com/explorer/license/
54 schema:sdPublisher Nb74f4340f8ac48a4a4daf7976534de88
55 schema:url http://link.springer.com/10.1007%2Fs11239-010-0463-7
56 sgo:license sg:explorer/license/
57 sgo:sdDataset articles
58 rdf:type schema:ScholarlyArticle
59 N02b2fedd64de41e88a7f711868a75c08 schema:issueNumber 1
60 rdf:type schema:PublicationIssue
61 N1225dbda177d44dd9625d98cb8a94ac4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
62 schema:name Acute Coronary Syndrome
63 rdf:type schema:DefinedTerm
64 N1254b93a55aa4144a9974a6651517cfc rdf:first sg:person.0750215673.07
65 rdf:rest N3ce5245682664a399559c088034d8ebc
66 N36e197056fdc4001b8c7d3aae79cad90 schema:name pubmed_id
67 schema:value 20354760
68 rdf:type schema:PropertyValue
69 N3ce5245682664a399559c088034d8ebc rdf:first sg:person.01172544713.06
70 rdf:rest rdf:nil
71 N4dc318b247dd4953adf15e1780614264 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Heptanoic Acids
73 rdf:type schema:DefinedTerm
74 N53b28a6119bd4b40a0ac8c0d4fdea666 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Female
76 rdf:type schema:DefinedTerm
77 N5598264e33704ae381e44be23b0c0fc3 rdf:first sg:person.0651160077.02
78 rdf:rest Na65bed3339eb4e9589d1de0803a35e70
79 N5b9ee280c5ca4a28aedd028161b5d05c schema:name readcube_id
80 schema:value 725003c384b0b39b8fde8a8e7c74992db0a04563afa2257dc46c92519374efd9
81 rdf:type schema:PropertyValue
82 N71b5a606f828479c819b7056a95a7c53 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Inflammation
84 rdf:type schema:DefinedTerm
85 N83f628dd53394e1eb4f246319d8960a4 schema:name nlm_unique_id
86 schema:value 9502018
87 rdf:type schema:PropertyValue
88 N89b1907acc2d4560bc544b2dade866fc schema:name Cardiovascular Division, Beth Israel/Deaconess Hospital, Harvard Medical School, Boston, MA, USA
89 rdf:type schema:Organization
90 N8aabf787ad294931bccbb3a5946a7ca7 schema:name dimensions_id
91 schema:value pub.1023994433
92 rdf:type schema:PropertyValue
93 N900eadc0a940476fb162bed93491db25 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Humans
95 rdf:type schema:DefinedTerm
96 N920adf81cf0549cbaf0b3a87e6f7565e schema:volumeNumber 30
97 rdf:type schema:PublicationVolume
98 N9a1309a29d6f48eda0748ef4b5e46951 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Hydroxymethylglutaryl-CoA Reductase Inhibitors
100 rdf:type schema:DefinedTerm
101 Na65bed3339eb4e9589d1de0803a35e70 rdf:first sg:person.01235024064.89
102 rdf:rest Nf85211490ad745fba54cb6e203a482e4
103 Nb02921f9121647d19e925076faa37bb7 schema:name doi
104 schema:value 10.1007/s11239-010-0463-7
105 rdf:type schema:PropertyValue
106 Nb1841e70596345d2b0860447cfb0382a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Pravastatin
108 rdf:type schema:DefinedTerm
109 Nb74f4340f8ac48a4a4daf7976534de88 schema:name Springer Nature - SN SciGraph project
110 rdf:type schema:Organization
111 Nb7fb28278b5948959a50545a615c8970 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Atherosclerosis
113 rdf:type schema:DefinedTerm
114 Nca26a2177bf64f2db8235c91d4378f1a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Pyrroles
116 rdf:type schema:DefinedTerm
117 Nd675d8b0c1c04dd9bbe1e8b5b7acc4f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Atorvastatin
119 rdf:type schema:DefinedTerm
120 Nde12b014ac2a464ab20a4f36619b3b95 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Male
122 rdf:type schema:DefinedTerm
123 Ne308b96c44344d008ba11ad8b857d0b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Treatment Outcome
125 rdf:type schema:DefinedTerm
126 Ne3cd39706e5d4e06be1c43f6dbd55839 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Observation
128 rdf:type schema:DefinedTerm
129 Nee67c799ac4c44d3a033b7a4618b74c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name C-Reactive Protein
131 rdf:type schema:DefinedTerm
132 Nf85211490ad745fba54cb6e203a482e4 rdf:first sg:person.01370013504.41
133 rdf:rest N1254b93a55aa4144a9974a6651517cfc
134 Nf8c7a6a9bfba4567a61dd8dc9d55af7d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Angioplasty, Balloon, Coronary
136 rdf:type schema:DefinedTerm
137 Nfdfd493bf40b4466bb40d97195f08ee0 schema:name Worldwide Clinical Trials, Nottingham, UK
138 rdf:type schema:Organization
139 Nfe53f92e89e143f28bd436ee622f72a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Middle Aged
141 rdf:type schema:DefinedTerm
142 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
143 schema:name Medical and Health Sciences
144 rdf:type schema:DefinedTerm
145 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
146 schema:name Clinical Sciences
147 rdf:type schema:DefinedTerm
148 sg:journal.1113719 schema:issn 0929-5305
149 1573-742X
150 schema:name Journal of Thrombosis and Thrombolysis
151 rdf:type schema:Periodical
152 sg:person.01172544713.06 schema:affiliation https://www.grid.ac/institutes/grid.492942.0
153 schema:familyName Cannon
154 schema:givenName Christopher P.
155 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172544713.06
156 rdf:type schema:Person
157 sg:person.01235024064.89 schema:affiliation https://www.grid.ac/institutes/grid.62560.37
158 schema:familyName Nazer
159 schema:givenName Babak
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235024064.89
161 rdf:type schema:Person
162 sg:person.01370013504.41 schema:affiliation Nfdfd493bf40b4466bb40d97195f08ee0
163 schema:familyName Cairns
164 schema:givenName Richard
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370013504.41
166 rdf:type schema:Person
167 sg:person.0651160077.02 schema:affiliation https://www.grid.ac/institutes/grid.5335.0
168 schema:familyName Ray
169 schema:givenName Kausik K.
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651160077.02
171 rdf:type schema:Person
172 sg:person.0750215673.07 schema:affiliation N89b1907acc2d4560bc544b2dade866fc
173 schema:familyName Michael Gibson
174 schema:givenName C.
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750215673.07
176 rdf:type schema:Person
177 https://doi.org/10.1016/j.amjcard.2003.09.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026083053
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1016/j.jacc.2005.03.077 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030759611
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1016/s0002-9149(02)02615-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029868075
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1016/s0008-6363(99)00175-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054580480
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1016/s0140-6736(05)67222-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036049136
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1056/nejm200106213442501 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025910550
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1056/nejmoa040583 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024700175
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1056/nejmoa042378 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040605046
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1067/mhj.2003.16 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037102433
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1067/mhj.2003.65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044385512
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1161/01.cir.0000060541.18923.e9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028923218
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1161/01.cir.104.2.163 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002436923
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1161/circulationaha.105.586347 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000843350
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1161/circulationaha.106.628909 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033284354
204 rdf:type schema:CreativeWork
205 https://www.grid.ac/institutes/grid.492942.0 schema:alternateName Thrombolysis in Myocardial Infarction Study Group
206 schema:name Thrombolysis in Myocardial Infarction (TIMI) Study Group, Cardiovascular Division, Brigham and Women’s Hospital and Harvard Medical School, 75 Francis St, 02115, Boston, MA, USA
207 rdf:type schema:Organization
208 https://www.grid.ac/institutes/grid.5335.0 schema:alternateName University of Cambridge
209 schema:name Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
210 rdf:type schema:Organization
211 https://www.grid.ac/institutes/grid.62560.37 schema:alternateName Brigham and Women's Hospital
212 schema:name Department of Internal Medicine, Brigham and Women’s Hospital, Boston, MA, USA
213 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...